The Indian Certificate of Secondary Education (ICSE) has started the Class 10 board examinations for the academic year 2026–27. The ICSE Class 10 Biology  exam 2026 was conducted from 11:00 am to 1:00 ...

At String Bio, Co-Founder and CEO Dr. Ezhil Subbian is developing solutions that increase agricultural yields while reducing emissions and sequestering methane. String Bio uses a proprietary ...

Company plans to initiate a Phase 1 clinical study by 1H2026 and share data in 2027 NEOK Bio, Inc., an oncology therapeutics company focused on the development of novel antibody drug conjugates (ADCs) ...

Class 11 is a pivotal year in a student’s life. The textbooks are much larger, there is a great deal of expectation from parents, teachers, and classmates, and the word JEE is gradually becoming more ...

Daniel is a News Writer from the United Kingdom. Relatively new to the industry with just over three years of experience, he has focused on establishing himself in the gaming space, with bylines in ...

Laigo Bio’s SureTAC™ membrane protein degradation technology targets key signaling molecules in autoimmune, graft rejection, and oncology UTRECHT, the Netherlands - 4 December 2025 (08:30 CET). Laigo ...

CBSE Class 11 Study Material - CBSE Class 11 Study Material 2026 is one of the most valuable resources for students preparing to build a strong academic foundation for their Class 12 and board-level ...

Nov 5 (Reuters) - Biotech firm Bio-Techne (TECH.O), opens new tab on Wednesday missed Wall Street estimates for first-quarter revenue, hurt by subdued demand for its products, sending its shares down ...

What was the structure and context of this transaction? This transaction involved the exercise of 100,000 stock options, immediately followed by the sale of the resulting shares in the open market.

Takara Bio USA, Inc. ("Takara Bio USA"), a wholly owned subsidiary of Takara Bio Inc. ("Takara Bio"), today announced a series of updates to its spatial biology product portfolio, extending its ...

New capabilities mark continued momentum as company advances discovery research applications and accelerates the global growth of its spatial biology business SAN JOSE, Calif.--(BUSINESS WIRE)--#ffpe- ...

WELLESLEY HILLS, Mass., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, today announced ...